Clinical Trials Sponsored by Dai, Guanghai

Total 8743 results

Dai, Guanghai

Unknown

Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

Advanced Biliary Tract Cancer

China
Kai-Yang Lv

Unknown

Virtual Reality Technology to Alleviate the Acute Pain of Scar Treatment With Fractional Laser Under Local Anesthesia

Acute Pain | Scar

China
argenx
Zai Lab (Shanghai) Co., Ltd.

Recruiting

A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)

Lupus Nephritis

China
MacroGenics
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)

Gastric Cancer | Gastroesophageal Junction Cancer | HER2-positive Gastric Cancer

Korea, Republic of, United States, China, Italy, Taiwan, Germany, Singapore, United Kingdom, Poland
Changhai Hospital
Shanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Pulmonary Hospital, Shanghai...

Unknown

Sedation Strategies for Therapeutic Bronchoscopy 2

Sedation | Bronchoscopy

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Unresectable, Recurrent or Metastatic Melanoma | Untreated Mucosal or Acral Lentiginous Melanoma

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Breast Cancer Metastatic

Taiwan
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumors

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of Niraparib in Patients With Relapsed Ovarian Cancer

Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Platinum-sensitive Relapsed Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With Imatinib

Gastrointestinal Stromal Tumor(GIST)

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
Changhai Hospital
Shanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Pulmonary Hospital, Shanghai...

Terminated

Sedation Strategies for Therapeutic Bronchoscopy

Sedation | Bronchoscopy

China
Changhai Hospital
Shanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Pulmonary Hospital, Shanghai...

Unknown

Sedation Strategies for Diagnostic Bronchoscopy 2

Sedation | Bronchoscopy

China
Changhai Hospital
Shanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Pulmonary Hospital, Shanghai...

Terminated

Sedation Strategies for Diagnostic Bronchoscopy

Sedation | Bronchoscopy

China
Shanghai Pulmonary Hospital, Shanghai, China
Nanjing Chia-tai Tianqing Pharmaceutical

Completed

Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis
Zai Lab (Shanghai) Co., Ltd.

Completed

To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies

Solid Malignancies

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Trial of ZL-1201 in Subjects With Advanced Cancer

Advanced Cancer

United States, China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Gastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract Carcinoma

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC

HER2 Positive Metastatic Breast Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC

Hepatocellular Carcinoma (HCC)

China
Zai Lab (Shanghai) Co., Ltd.

Completed

The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer

Ovarian Cancer

China
Fudan University
Changhai Hospital; Shanghai East Hospital; Shanghai Changzheng Hospital

Not yet recruiting

Wound Management Following Gl Tumor Surgery: Comparing Outcomes of Dressing Changes Versus Non-Dressing Techniques (Dressing)

Pain, Postoperative | Surgical Wound Infection | Gastrointestinal Tumors

China
Zai Lab (Shanghai) Co., Ltd.
Zai Lab (US) LLC

Recruiting

An Open-label, Multicenter Study of ZL-1310 in Subjects With Small Cell Lung Cancer

SCLC

United States
Karuna Therapeutics
Zai Lab (Shanghai) Co., Ltd.

Recruiting

A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia (UNITE-001)

Schizophrenia

China
Incyte Corporation
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer (POD1UM-304)

Metastatic Squamous Non-Small Cell Lung Cancer | Metastatic Nonsquamous Non-Small Cell Lung Cancer

China, Czechia, Russian Federation, Serbia, Malaysia, Vietnam, United States, Poland, Ukraine, Romania, Turkey, Brazil, Bulgaria, Georgia, Hungary, Philippines, South Africa
Xijing Hospital
Changhai Hospital; Shanghai Zhongshan Hospital

Unknown

Hybrid Operation in Thoracic Aortic Dissection

Aorta Dissection | Aorta Aneurysm

China
Shanghai Chest Hospital
Changhai Hospital; Ruijin Hospital

Unknown

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Changhai Hospital; RenJi Hospital; Shanghai 10th People's Hospital; Ruijin Hospital

Recruiting

Systematic Sampling of Lymph Nodes vs. Lymphadenectomy According to Intraoperative Frozen Pathology for Pulmonary Invasive Adenocarcinoma With Ground-glass Opacity

Lymph Node Excision

China
Bristol-Myers Squibb
Zai Lab (Shanghai) Co., Ltd.

Recruiting

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

Carcinoma, Non-Small-Cell Lung

Japan, China, Spain, Germany, Korea, Republic of, Austria, Brazil, Romania, France, United States, Italy, Argentina, Canada, Chile, Greece, Hungary, India, Poland, Turkey, Switzerland, Netherlands
Xin Cai

Not yet recruiting

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

Rectal Cancer | Recurrent

China
ShangHai Ji Ai Genetics & IVF Institute

Not yet recruiting

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

GnRH Antagonist | Polycystic Ovarian Syndrome | Preimplantation Genetic Testing | Progestin-primed Ovarian Stimulation
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

Effect of Acupuncture on the Clinical Outcome of IVF-ET in Patients With Recurrent Implantation Failure

Acupuncture | Recurrent Implantation Failure

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

The Clinical Efficiency of Tb-ERA in Chinese RIF Patients

Endometrial Receptivity | Repeated Implantation Failure

China
ShangHai Ji Ai Genetics & IVF Institute

Completed

Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?

Miscarriage

China
Ai Peng

Unknown

The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients

Hemodialysis Complication

China
Ai Peng

Unknown

Role of Uralyt-U in Patients With Hyperuricemia

Hyperuricemia | Uric Acid Stones

China
ShangHai Ji Ai Genetics & IVF Institute

Completed

Effects of PGS in Infertile Female Patients With RPL

Abortion, Habitual | Infertility, Female

China
ShangHai Ji Ai Genetics & IVF Institute

Unknown

The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders (DHEA)

Infertility

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

The Impact of Past Coronavirus Disease 19 (COVID-19) Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles

COVID-19 | Frozen Embryo Transfer

China
Ai Peng

Recruiting

Clinical Evaluation Study of a Device for Detecting Arteriovenous Fistula Vascular Function

Arteriovenous Fistula Flow Monitoring | Early Detection of Complications of Arteriovenous Fistula | Voiceprint

China
Ai Peng

Recruiting

Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

Gout Flare | Intercritical Gout | Advanced Gout | Asymptomatic Hyperuricemia

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

Effect of GH on the Blastocyst Euploid Rate in AMA Patients

Preimplantation Genetic Testing | Growth Hormone | Age, Parental

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

Follicular Fluid Raman Shifts and IVF Outcomes

Polycystic Ovary Syndrome | IVF

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A

GnRH Antagonist | Preimplantation Genetic Testing | Progestin-primed Ovarian Stimulation | Euploid Rate

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy (FET)

Frozen Embryo Transfer | IVF

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF

Infertility | ART

China
ShangHai Ji Ai Genetics & IVF Institute

Completed

Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response

GnRH Antagonist | IVF | PPOS

China

Clinical Trials Sponsored by Dai, Guanghai

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations